title: Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.
authors.forename: Maciej
authors.initials: M
authors.lastname: Kwiatkowski
authors.forename: Laurence
authors.initials: L
authors.lastname: Klotz
authors.forename: Jonas
authors.initials: J
authors.lastname: Hugosson
authors.forename: Franz
authors.initials: F
authors.lastname: Recker
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D055088:Early Detection of Cancer; D019317:Evidence-Based Medicine / Q000592:standards; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000592:standards*; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D011314:Preventive Health Services / Q000592:standards*; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000401:mortality / Q000517:prevention & control; D014481:United States
chemical_list: D017430:Prostate-Specific Antigen